Intraarterial chemotherapy and chemoembolization in head and neck cancer. Establishment as a neoadjuvant routine method

Current aspects in the treatment of patients with relapsed or refractory testicular cancer

Gene expression profiles related with overcoming cisplatin resistance in human cancer cell lines

Overexpression of angiogenic growth factors in lung cancer cells is associated with cisplatin resistance

Cisplatin nephrotoxicity: molecular mechanisms

Mitoxantrone, prednisone, pentostatin and bleomycin for patients with indolent non-Hodgkin’s lymphoma relapsed or unresponsive to previous treatments. Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (GISL)

Chemotherapy in elderly patients with advanced breast cancer

 

Drug resistance in breast cancer

Screening for lung cancer: a review and current status

Expression of RB1CC1, a novel tumor suppressor gene, is inversely correlated with the Ki-67 proliferation index in primary breast cancers

Approaches to the treatment of brain tumors using cytokine-secreting allogeneic fibroblasts

Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carcinoma in a phase I/II trial

Electrochemotherapy: advantages and drawbacks in treatment of cancer patients

p16 downregulates VEGF and inhibits angiogenesis in breast cancer cells

Basic fibroblast growth factor antisense oligonucleotides inhibit renal cell carcinoma cell growth and angiogenesis

Antitumoral cell-based therapies

Can mortalin be a candidate target for cancer therapy?

Therapeutic potential of antinuclear autoantibodies in cancer

Filgrastim use: evaluation in cancer and critically ill non- cancer patients

Yolande B. Saab, Leyla Sharaf, Ismail Zeidan

Gemcitabine, cisplatin, fluorouracil and folinic acid as first line treatment of locally advanced and/or metastatic pancreatic cancer: a phase II study of the gruppo oncologico dell’Italia meridionale (G.O.I.M.)

Phase I study of high dose 5-fluorouracil and folinic acid in weekly continuous infusions

High-dose methotrexate with citrovorum factor for malignant fibrous histiocytoma of soft tissue: a cell culture study

Phase II intergroup trial of sequential chemotherapy and radiotherapy for AIDS-related primary central nervous system lymphoma

Sentinel lymph node biopsy for breast cancer: addressing the controversies

A randomised, double-blind, phase II study of three different marimastat schedules administered to patients with resected Dukes C colorectal cancer

LY900003: A novel compound for the treatment of non-small cell lung cancer

Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis

Expression of insulin-like growth factors and their receptors in malignant fibrous histiocytoma of soft tissues

Tetsuji Yamamoto , Toshihiro Akisue, Tetsuya Nakatani, Takashi Marui, Ikuo Fujita, Keiji Matsumoto, Toshiaki Hitora, Teruya Kawamoto, Keiko Nagira, Masahiro Kurosaka

Ethical, cultural and religious aspects of hereditary cancer in Jewish communities

Selective intraarterial cisplatin chemotherapy in treatment of advanced malignant squamous cell carcinoma of the head and neck

Protein kinase C-delta and its downstream effectors as potential targets for cancer therapy

Jihua Liu, David Durrant and Ray M. Lee* Huntsman Cancer Institute and Section of Oncology, Department of Internal Medicine, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112

A Phase I safety and imaging study using radiofrequency ablation (RFA) followed by 131I-chTNT-1/B radioimmunotherapy adjuvant treatment of hepatic metastases

Peter M. Anderson1,2,3*, Gregory A. Wiseman3,4, Bradley D. Lewis5, J. William Charboneau5, William L. Dunn4, Susan P. Carpenter6, Terrence Chew6

Dept. of Pediatrics1, Internal Medicine (Hematology)2, and Mayo Clinic Comprehensive Cancer Center3, Nuclear Medicine4, and Radiology5, Mayo Clinic, Rochester MN, Peregrine Pharmaceuticals6, Tustin CA

Allelic loss at the SEP15 locus in breast cancer

Mohamed A. Nasr, Ya Jun Hu, and Alan M. Diamond*

Department of Human Nutrition, University of Illinois at Chicago, Chicago, IL 60612

Dendritic cell based vaccines for immunotherapy of cancer

Asim Saha, Sunil K. Chatterjee, Kartik Mohanty, Kenneth A. Foon1, Malaya Bhattacharya-Chatterjee*

Department of Internal Medicine and the Barrett Cancer Center, University of Cincinnati, Ohio 45267
1University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232

Multitargeted antifolate (Pemetrexed): A comprehensive review of its mechanisms of action, recent results and future prospects

Delphine Exinger1, Françoise Exinger2, Bertrand Mennecier3, Jean-Marc Limacher1, Patrick Dufour1, Jean-Emmanuel Kurtz 1,2,*

1 Department of Hematology and Oncology, Hôpitaux Universitaires de Strasbourg, 1 Avenue Molière, 67098-F Strasbourg France; 2 Laboratoire de Génétique, UPR 9003 du CNRS, IRCAD, 1 place de l’Hôpital, 67000-F Strasbourg France; 3 Service de Pneumologie, Hôpital Lyautey, 1 rue des Cannoniers, 67100-F Strasbourg France

Molecular therapy of gastric cancer

Jie Chen1, Minhu Chen2, Christoph Röcken 3, Tobias Götze1, Peter Malfertheiner1 and Matthias P.A. Ebert1

1Department of Gastroenterology, Hepatology and Infectious Diseases, and 3Institute of Pathology, Otto-von-Guericke University, Magdeburg, Germany; 2Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

Tumor angiogenesis as a strategy for radiosensitization

Bo Lu, Dong W. Kim, Dennis E. Hallahan1,3*

1Department of Radiation Oncology, Vanderbilt School of Medicine, Vanderbilt University, 2Department of Radiology, Vanderbilt School of Medicine, Vanderbilt University, 3 Department of Biomedical Engineering, Vanderbilt School of Engineering, Nashville, TN

p14 ARF: Role in the cellular stress response and applications to cancer

Yinghui Huang and Ruth A. Gjerset

Sidney Kimmel Cancer Center, 10835 Altman Row, San Diego, CA 92121

The role of B lymphocytes in breast cancer: a review and current status

Sazini Nzula 1*, James J. Going 2, David I. Stott 1

1Division of Immunology, Infection & Inflammation and 2Division of Cancer Sciences & Molecular Pathology, University of Glasgow, Western Infirmary, Glasgow, G11 6NT, Scotland, U.K.

Advances in breast cancer therapy and chemoprevention: current strategies and new approaches

Treatment planning in endometrial cancer

Dendritic cell-mediated immunosuppression in malignant melanoma

Marta E Polak, Nicola J Borthwick, Martine J Jager, Ian A Cree